Hu Hongdan
executive director @ Med-Fine Capital
Hu Hongdan is a Series A investor at Med-Fine Capital. Hu Hongdan is executive director of Mifang Health Fund.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Stages Hu Hongdan invests in
Countries Hu Hongdan invests in
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Degron Therapeutics
|
Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment. | $22M / Series A / Jun 09, 2022 |
Co-Investors
About Med-Fine Capital
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Med-Fine Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Hu Hongdan
executive director
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
FAQ
When did Hu Hongdan last invest?
The most recent investment recorded for Hu Hongdan closed in Jun 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
